Evidence map›Paper›PMID 39468091›Full record

ArticleScientific reports2024

Cardiometabolic risk factor clusters in older adults using latent class analysis on the Bushehr elderly health program.

Sima Afrashteh, Zahrasadat Jalalian, Nima Daneshi, Ali Jamshidi, Jonathan A Batty, Haniye Mahdavizade, Akram Farhadi, Hasan Malekizadeh, Iraj Nabipour, Bagher Larijani

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sima Afrashteh *Department of Biostatistics and Epidemiology, Faculty of Health and Nutrition, Bushehr University of Medical Sciences, Bushehr, Iran.
Zahrasadat Jalalian *School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Nima DaneshiDepartment of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Ali JamshidiThe Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.
Jonathan A BattyLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Haniye MahdavizadeStudent Research Committee, Bushehr University of Medical Sciences, Bushehr, Iran.
Akram FarhadiThe Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran. Ak.farhadi@gmail.com.ORCID http://orcid.org/0000-0003-4333-4126
Hasan MalekizadehSchool of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Iraj NabipourThe Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.
Bagher LarijaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MetS), comprising obesity, insulin resistance, hypertension, and dyslipidemia, increases the risk of type II diabetes mellitus and cardiovascular disease. This study aimed to identify the prevalence and determinants of specific clusters of the MetS components and tobacco consumption among older adults in Iran. The current study was conducted in the second stage of the Bushehr Elderly Health (BEH) program in southern Iran-a population-based cohort including 2424 subjects aged ≥ 60 years. Latent class analysis (LCA) was used to identify MetS and tobacco consumption patterns. Multinomial logistic regression was conducted to investigate factors associated with each MetS class, including sociodemographic and behavioral variables. Out of 2424 individuals, the overall percentage of people with one or more components of MetS or current tobacco use was 57.8% and 20.8%, respectively. The mean (SD) age of all participants was 69.3(6.4) years. LCA ascertained the presence of four latent classes: class 1 ("low risk"; with a prevalence of 35.3%), class 2 ("MetS with medication-controlled diabetes"; 11.1%), class 3 ("high risk of MetS and associated medication use"; 27.1%), and class 4 ("central obesity and treated hypertension"; 26.4%). Compared to participants with a body mass index (BMI) < 30, participants with BMI ≥ 30 were more likely to belong to class 3 (OR 1.91, 95% CI 1.31-2.79) and class 4 (OR 1.49, 95% CI 1.06-2.08). Polypharmacy was associated with membership in class 2 (OR 2.07, 95% CI 1.12-3.81), class 3 (OR 9.77, 95% CI 6.12-15.59), and class 4 (OR 1.76, 95% CI 1.07-2.91). The elevated triglyceride-glucose index was associated with membership in class 2 (OR 12.33, 95% CI 7.75-19.61) and class 3 (OR 12.04, 95% CI 8.31-17.45). Individuals with poor self-related health were more likely to belong to class 3 (OR 1.43; 95% CI 1.08-1.93). Four classes were identified among older adults in Iran with distinct patterns of cardiometabolic risk factors. Segmenting elderly individuals into these cardiometabolic categories has the potential to enhance the monitoring and management of cardiometabolic risk factors. This strategy may help reduce the severe outcomes of metabolic syndrome in this susceptible population.

Indexed as

Cardiometabolic Risk FactorsLatent Class AnalysisMetabolic SyndromeAgedCardiovascular DiseasesDiabetes Mellitus, Type 2FemaleHumansHypertensionIranMaleMiddle AgedPrevalenceRisk FactorsCardiometabolicLatent class analysisMetabolic syndromeOlder adults

Identifiers

PMID39468091
PMCPMC11519348

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.